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Are Genotoxic Carcinogens More Potent
Than Nongenotoxic Carcinogens?
by Silvio Parodi,* Davide Malacarne,t Paolo
Romano,' and Maurizio Taningher*
Inthisreportwehaveraisedthequestionwhethergenoto5dccarcinogensaremorepotentthannongenotoxkcarcinogens
whenstudied inlong-tern carcinogenicity assaysinrodents. Tobuildalargedatabaseofcompounds forwhichbothcar-
cinogenicity andgenotoxicity hadbeeninvestigated, wehaveusedadatabaseproducedbyGoldandco-workersforcar-
cinogenic potencydata(975chemicals)andadatabaseproducedbyWurglerforgenotoxicitydata(2834chemicals). Con-
sideringcompoundspositiveornegativeinatleastthreeshort-term testsandinatleast75%ofavailable tests, wecould
define67genotonccarcinogensand46nongenotoccarcinoges. Carcinogenicpotencyofgenooxiccarcinogenswasabout
50timeshigherthancarcinogenicpotencyofnongenotoricarcinogens. OurresultsaredifferentfromtheresultsofTlnnant
etal.; theirdatabase(24genotoxiccarcinogensand 12nongenotoxiccarcinogenscompatible withourdefinition) seems
to suggest thatthere ispracticaly no difference in potency between genotoxic and nongenotoxic carcinogens. The two
databaseshaveonlyfourcompoundsincomonandarealsodifferentinternsofnumberofeementsfordifferentchemical
classes. Nitrosocompounds, nitrogen mustards, hydrazine derivatives, and polycyclic aromatic hydrocarbons are not
representedinthedatabaseofTennant. Theoveral impressionfromouranalysisisthattheusefulnessofshort-termtests
ofgenotoxicity couldbesignificantly betterthanwhat hasbeensuggestedbythepreviousworkofTennant etal. because
theseteststendtodetect, atleastformanyimportant chemicalclasses, themost potentcarcinogens. Thisconsideration
may not bevalid forcertainclasses ofchenmcals.
Introduction
In a recent work (I), the capability of short-term tests in
predicting carcinogenicity has been found to be much more
limited thantheestimates ofprevious assessments (2,3). Using
equilibrated databases with similar numbers ofgenotoxic and
nongenotoxicchemicals, assayedinshort-term tests, andsimilar
numbersofcarcinogenic andnoncarcinogenic chemicalsassayed
in rodentexperiments, wecould expect a50% agreementofthe
two typesofresultsjustbychance. Theactuallevelofagreement
observed by Tennant et al. in their study (1) was only approx-
imately 60%.
Inthis work wewanted toinvestigate adifferent aspectofthe
relationshipbetweengenotoxicity andcarcinogenicity. Wethus
askedthequestion: Aregenotoxiccarcinogens, on average, more
potentandtherefore moredangerousthannongenotoxicones? As
short-term tests for epigenetic and/or promoting activities are
currently notavailable, we could expect that ifcarcinogenicity
is afunctionofbothgenotoxicity andepigenetic-promoting ac-
tivities, chemicals evaluated as genotoxic can have both ac-
tivities, while chemicals evaluated as nongenotoxic can
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have at most have only one. Therefore, genotoxic chemicals,
fromthepointofview ofpotential carcinogenicity, start with a
kind ofadvantage in respect to nongenotoxic agents.
Forbothcarcinogenicity andgenotoxicity wehavetriedusing
a larger database to obtain a reasonably large intersection
database between carcinogenicity studies and genotoxicity
studies. We are aware that literature-based evaluations can be
subjected topotential bias infavorofeitherclearlygenotoxic or
clearly carcinogenic compounds because itis sometimeseasier
topublishpositiveratherthannegativeresults. Weanalyzethis
problem afterpresenting our results.
Methods and Results
As adatabase forcarcinogenic potency, weusedthatofGold
etal. (4-6). Inthisdatabase, 975 chemicals aredescribed, and
492 aredefinedascarcinogens (8) because tumorincidence in
treatedanimalswasfoundtobesignificantlyhigherthanincon-
trolanimals(inatleastonetargettissueoralltissuestogether),
according totheconclusionsoftheauthorsoftheexperimental
work. The other 483 chemicals can be defined as doubtful or
negative and were not used in our study. As a database for
genotoxicity, weusedWurgler'sdatabase(7). Inthisdatabase,
2834 chemicals and 95 different types ofresults are reported.
Amongthem, 76typesofgenotoxicitytests areconsidered; they
can be subdivided in the following categories: repair tests,
bacterial mutationassays, fungal assays, Drosophila assays, in
vitroandin vivomammalian assays. WeusedonlygenotoxicityPARODIETAL.
Tible 1. Intersection database from Goldetal. (8) andWiirgler (7): chemicals positiveornegativeinatleastthree testsandinatleast75%ofavailabletests.
CAS number Chemical name Log O(TD50)8 CAS number Chemical name Logio(TD50)"
Genotoxic chemicals
*b 50-00-0 Formaldehyde
* 50-07-7 Mitomycin-C
* 50-18-0 Cyclophosphamide
* 51-75-2 Nitrogen mustard
* 52-24-4 Thio-tepa [tris(l-aziridinyl)phosphine sulfide)
53-70-3 Dibenz[a,hJanthracene
* 53-95-2 N-Hydroxy-2-acetylaminofluorene
* 55-18-5 N-Nitrosodiethylamine
57-39-6 Metepa
* 57-57-8 ,B-Propiolactone
* 57-97-6 7,12-Dimethylbenz[alanthracene
* 62-75-9 N-Nitrosodimethylamine
* 66-27-3 Methyl methanesulfonate
* 68-76-8 Trenimon
* 70-25-7 N-Methyl-N'-nitro-N-nitrosoguanidine
* 75-09-2 Methylene chloride
* 75-21-8 Ethylene oxide
79-34-5 1,1,2,2-Tetrachloroethane
* 79-44-7 Dimethylcarbamil chloride
* 96-12-8 1,2-Dibromo-3-chloropropane
* 100-75-4 N-Nitrosopiperidine
* 100-93-4 1,2-Dibromoethane
* 107-06-2 1,2-Dichloroethane
* 107-13-1 Acrylonitrile
109-84-2 2-Hydroxyethylhydrazine
* 115-02-6 Azaserine
* 117-39-5 Quercetin
* 126-72-7 Tris(2,3-dibromopropyl)phosphate
127-18-4 Tetrachloroethylene
* 140-79-4 Dinitrosopiperazine
* 148-82-3 Melphalan
* 151-56-4 Ethylene imine
305-03-3 Chlorambucil
* 315-22-0 Monocrotaline
* 512-56-1 Trimethylphosphate
531-82-8 N-4-(5-Nitro-2-furyl)-2-thiazolylacetamide
602-87-9 5-Nitroacenaphtene
* 614-95-9 Nitrosoethylurethan
* 621-64-7 N-Nitrosodipropylamine
758-17-8 N-Methyl-N-formylhydrazine
* 759-73-9 1-Ethyl-I-nitrosourea
* 869-01-2 N-N-Butyl-N-nitrosourea
924-16-3 Nitrosodibutylamine
930-55-2 N-Nitrosopyrrolidine
1068-57-1 Monoacetyl hydrazine
* 1120-71-4 Propane sultone
* 1162-65-8 Aflatoxin B,
2318-18-5 Senkirkine
3544-23-8 3-Methoxy-4-aminoazobenzene
3570-75-0 Formic acid2-4-(5-nitro-2-furyl)-2-thiazolyl
hydrazide
* 3688-53-7 2-(2-Furyl)-3-(5-nitro-2-(furyl)acrylamide
5307-14-2 2-Nitro-p-phenylenediamine
* 7227-91-0 1-Phenyl-3,3-dimethylatriazene
* 18883-66-4 Streptozotocin
22571-95-5 Symphytine
* 24554-26-5 N-4(5-Nitro-2-furyl)-2-thiazolylformamide
25843-45-2 Azoxymethane
26049-69-4 2-(2,2-Dimethylhydrazino)-4-(5-nitro-
2-furyl) thiazole
-0.10
-3.01
0.10
-1.94
-0.91
0.77
-3.16
-2.10
0.65
0.06
-1.08
-1.23
1.50
-2.30
-0.28
2.78
0.87
1.55
0.73
-0.97
0.11
0.04
0.74
0.73
-0.50
-0.10
0.71
0.20
1.88
0.30
-1.14
-0.55
-1.01
-0.10
2.53
1.02
0.78
-0.61
-0.73
-0.13
-0.04
-40.04
-0.16
0.19
0.65
0.56
-3.03
0.23
1.78
0.55
1.06
2.79
0.36
-0.71
0.28
0.12
-1.52
-0.39
26148-68-5 2-Amino-9H-pyrido(2,3-b) indole
28754-68-9 trans-5-Amino-3 2-(5-nitro-2-furyl)
vinyl-I,2,4-oxadiazole
38777-13-8 Nitroso-baygon
42011-48-3 2,2,2-Trifluoro-N-4-(5-nitro-2-furyl)-2-thi-
azolylacetamide
54749-90-5 Chlorozotocin
67730-10-3 2-Aminodipyrido 1,2-a:3 ',2'-d-imidazole
67730-11-4 2-Amino-6-methyldipyrido- 1,2-a:3',2'-d-
imidazole
68006-83-7 2-Amino-3-methyl-9H-pyrido- 2,3-b -indole
76180-96-6 2-Amino-3-methylimidazo- 4,5-fquinoline
Nongenotoxic chemicals
*b 50-06-6 Phenobarbital
* 56-53-1 Diethylstilbestrol
* 57-14-7 1,I-Dimethylhydrazine
* 57-30-7 Phenobarbital sodium
* 60-34-4 Methylhydrazine
* 60-35-5 Acetamide
* 60-57-1 Dieldrin
* 60-80-0 Phenazone
* 61-82-5 3-Aminotriazole
* 62-55-5 Thioacetamide
* 62-56-6 Thiourea
* 63-25-2 Carbaryl
* 64-17-5 Ethyl alcohol
* 67-72-1 Hexachloroethane
* 72-55-9 p,p'-DDE
* 76-44-8 Heptachlor
* 82-68-8 Pentachloronitrobenzene
* 86-30-6 N-Nitrosodiphenylamine
* 88-06-2 2,4,6-Trichlorophenol
* 88-19-7 o-Toluenesulfonamide
94-58-6 Dihydrosafrole
* 95-06-7 Sulfallate
* 102-71-6 Triethanolamine
* 108-05-4 Vinyl acetate
* 117-81-7 Di(2-ethylhexyl)phthalate
* 128-37-0 Butylated hydroxytoluene
* 128-44-9 Saccharin sodium
* 309-00-2 Aldrin
* 518-75-2 Citrinin
* 569-61-9 p-Rosaniline HCI
* 842-07-9 1-Phenylazo-2-naphthol
* 915-67-3 FD&C red no. 2
* 1582-09-8 Trifluralin
* 1694-09-3 FD&C violet no. I
* 2303-16-4 Diallate
* 3564-09-8 FD&C red no. 1
3761-53-3 FD&C red no. 5
* 4548-53-2 FD&C red no. 4
* 5141-20-8 FD&C green no. 2
* 5208-87-7 1 '-Hydroxysafrole
* 13073-35-3 Ethionine
* 17924-92-4 Zearalenone
* 21884-44-6 Luteoskyrin
* 25013-16-5 Butylated hydroxyanisole
51410-44-7 1 '-Hydroxyestragole
56222-35-6 N-Nitroso-3-hydroxypyrrolidine
'TD5o is defined as "that chronic dose rate (in mg/kg body weight/day) which would halve the actuarially adjusted percentage of tumor free animals at the
end of a standard experiment time (the 'standard lifespan' for the species)" (9). When TD50 values both for mice and rats were available in the summary
database of Gold et al. (8), the lower value was used. In that database, thejudgment about the positivity of results is left to the authors of the experimental
work. For a very small nuniber of chemicals, Gold points out that the overall statistical significance of the results seems questionable. In this case we have
accepted as positive only chemicals for which we could find, at least for a specific tissue, a statistical significance with p < 0.05, two-tailed, in the detailed
databases of Gold et al. (4-6).
'The asterisk indicates that the compound was positive or negative in at least six tests and at least 75% of available tests.
1.55
2.02
-0.44
0.83
-1.62
1.08
0.51
1.19
1.24
0.62
-1.59
0.32
1.54
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2.02
-0.33
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1.15
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data, discarding other types of information concerning car-
cinogenicity, promotingactivity, plant systemsandpooleddata.
The results were treated by Wurgler (7) with a qualitative ap-
proach and defined as clearly positive, clearly negative, and
questionableresults. Wehavenotconsideredquestionable results
in our study.
Wehavedirectly examinednearly all thepublicationsthat are
sources forWurgler'sdatabase. From ouranalysis, approximate-
lythree outoffourshort-term tests wereperformedin vitroand
approximately 25% were performed in vivo. For the tests per-
formed in vitro, anacceptablemetabolic activation was present
in about 50% ofthe cases.
As a consequence, wehave accepted a situation in which ap-
proximately 37% ofthe totality (in vitro + in vivo) ofthe tests
performed iswithoutmetabolic activation. Mostlikely, because
ofthis fact, somegenotoxiccompoundsbecamedoubtful com-
pounds and some doubtful compounds became nongenotoxic
ones. However, the relative difference between the two
subclasses should have remained substantially the same.
The intersection ofthedatabases ofGold etal. and Wurgler
made itpossible tobuild adatabaseaboutthreetimeslargerthan
thatofTennant etal. (1). Tobuild ourintersectiondatabase we
haveposed the following conditions: a) the chemical had to be
apositivecarcinogen according tothedatabaseofGoldetal. (8);
b) the chemical had to bepositive, ornegative, in atleastthree
testsand in atleast75% ofthe cases, tobedefined asgenotoxic
or nongenotoxic. From our intersection database we found 113
chemicals that satisfied both conditions (Table 1).
TreatingthedatabaseofTennantetal. (1) in asimilar way, we
found 36 chemicals that satisfied conditions a and b (Table 2).
Ourdatabaseincludesonly4outofthe36chemicalsofTennant's
database (1,2-dibromo-3-chloropropane, 1,2-dibromoethane,
di(2-ethylhexyl)phthalate, I-phenylazo-2-naphthol).
For carcinogenic potency, Tennant gives the maximum tol-
erateddosethat wasadministered, wherasGoldgivestheTD50.
It was easy toextrapolate aTD50 forthedata ofTennant. Using
thepositivecarcinogens in common (32chemicals) betweenthe
databasesofGoldetal. (8)andTennantetal. (1)(492and44 car-
cinogens, respectively), we correlated the maximum tolerated
dose of Tennant and the TD50 of Gold. The equation of the
regression line linking the two variables is y = 0.04 + 1.06x,
where y = log,0(TD50) andx = logI0(maximumtolerateddose).
Thecorrelationbetweenthe twoparameters wasgood(r = 0.97
for32compounds). Usingthisequation wecould express(Tables
2 and3)thecarcinogenicpotenciesofTennant intermsofTD50.
Thedatabaseconcerning our 113 compounds is showninTable
1. Thecompounds have aroughly log-normaldistribution, as ex-
pected (10).
In our database, we compared the carcinogenic potency of
genotoxic and nongenotoxic carcinogens. The results obtained
are shown inTable 3. Table 3clearly showsthatgenotoxic com-
pounds are morepotentthannongenotoxic ones. Genotoxic com-
punds are about 50 times more potent for information coming
from atleastthree tests (Fig. 1) andabout 100times morepotent
for information coming from at least six tests (Fig. 2). In both
casesthedifferences are statistically significant. (p < 0.0005).
To get an ideaoftheimportance ofthedifference, we can con-
siderthefollowing: InFigure 1, onlyabout8.2% ofnongenotoxic
carcinogens falls into the half to the left of the log-normal
Table2. Database ofTennantetal. (1).
CAS number Chemical name Log1o(TD O)a
Genotoxic chemicals
57-06-7 Allyl isothiocyanate 1.36
75-56-9 Propylene oxide 1.83
78-87-5 1,2-Dichloropropane 2.10
96-12-8 1,2-Dibromo-3-chloropropane -0.51
101-80-4 4'-4'-Oxydianiline 0.99
101-90-6 Diglycidyl resorcinol ether 1.03
106-93-4 1,2-Dibromoethane 0.68
108-6 I bis(2-Chloro-I-methylethyl)ether 2.00
137-30-4 Ziram 1.50
140-88-5 Ethyl acrylate 2.00
542-75-6 1,3-Dichloropropene 1.45
563-47-3 3'-Chloro-2-methylpropene 2.00
597-25-1 Dimethyl morpholinophos-
phoramidate 2.83
609-20-1 2,6-Dichloro-p-phenylenediamine 2.75
842-07-9 C.I. solventyellow 14 1.41
868-85-9 Dimethyl hydrogen phosphite 2.32
2185-92-4 2-Biphenylamine2HC1 2.78
2784-94-3 HC blue 1 2.34
2832-40-8 C.I. disperse yellow 3 2.47
2835-39-4 Allyl isovalerate 1.78
7446-34-6 Selenium sulfide 1.28
13552-44-8 4,4'-Methylenedianiline 2HC1 1.03
21739-91-3 Cytembena 0.55
26471-62-5 2,4- and 2,6-Toluene diisocyanate 1.77
Nongenotoxic chemicals
50-55-5 Reserpine -0.70
71-43-2 Benzene 1.36
78-42-2 tris(2-Ethylhexyl)phosphate 3.06
85-68-7 Butyl benzyl phthalate 2.98
87-29-6 Cinnamyl anthranilate 3.30
108-78-1 Melamine 2.43
117-81-7 di(2-Ethylhexyl)phthalate 2.66
140-11-4 Benzyl acetate 2.74
1746-01-6 2,3,7,8-Tetrachlorodibenzo-p-dioxin -5.26
2432-99-7 1 1-Aminoundecanoic acid 2.67
5160-02-1 FD&C red no. 9 1.73
67774-32-7 Polybrominated biphenyl mixture -0.70
aLog1o(TD5o) calculated according to the equation y=0.04+ 1.06x,where
y=1og10(TD50) andx=log 0 (maximumtolerateddose), asexplained inthetext.
Table3. Carcinogenic potenciesofchemicalspositiveornegativeinatleast
three testsandat least 75% ofavailable tests.
No. of Mean valuea Median valuea
chemicals (SE) (I-III quartile range)
Intersection database ofGold et al. (8) and Wurgler (7)
Genotoxic 67 1.19 (1.44) 1.31 (0.246-6.03)
Nongenotoxic 46 52.5 (1.49) 64.1 (8.51-355)
Genotoxicb 39 0.53 (1.63) 0.904 (0.105-3.63)
Nongenotoxicb 42 52.2 (1.55) 49.5 (7.76-380)
Database ofTennant etal. (I)
Genotoxic 24 45.3 (1.45) 60.0 (12.3-185)
Nongenotoxic 12 22.7 (5.24) 350 (0.653-834)
aThevalues arereported asTD30, definedas "thatchronicdose rate (inmg/kg
body weight/day) whichwouldhalvetheactuariallyadjustedpercentageoftumor-
freeanimalsattheendofastandardexperimenttime(the 'standardlifespanfor
the species')" (9). The original means and SE were computed on Log TD50
because we are dealing with a log-normal distribution: the mean should be
multiplied ordivided by SE (geometrical mean).
bGenotoxic or nongenotoxic carcinogens positive or negative in at least six
tests and at least 75% ofavailable tests.
distribution of genotoxic carcinogens (the 50% most potent
ones). Thisistrueifatleastthreeshort-termtestsareconsidered.
Ifat least six short-term tests are considered (Fig. 2), then the
8.2% is reduced to 5.2% (a ratio ofapproximately 10 to 1 be-
tweenthemostpotentgenotoxicandthemostpotentnongenotox-
ic carcinogens).
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FIGURE 1. Distribution oflog(TD50) for genotoxic (shaded bars) and non-
genotoxic (openbars)carcinogens positive ornegative in at leastthree tests
and at least 75% ofthe tests.
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FIGURE 2. Distribution of log(TD50) for genotoxic (shaded bars) and non-
genotoxic (open bars) carcinogens positive or negative in at least six test and
at least 75% ofthe tests.
We have treated the database ofTennant et al. (I) in the same
way as our database. We select 36 chemicals from Tennant's
database satisfying our conditions a and b. The database we
obtained is summarized in Table 2. In this case genotoxic com-
pounds are only 5.3 times more potent than nongenotoxic
compounds in terms ofmedian value; there is practically no dif-
ference when means are compared, especially as a consequence
ofthe extremely high potency ofTCDD (see Table 3).
The behaviorofTennant's database is essentially thebehavior
of all the compounds of the U.S. NTP database. From the
analysis of Brown and Ashby (11), genotoxic carcinogens and
nongenotoxic carcinogens in the NTP database, defined for their
response in Salmonella and for structural alert, have a similar
distribution in terms of range of potencies, only with a larger
range of potency values for nongenotoxic carcinogens. In con-
trast, in the Gold-Wurgler's database (Figs. 1 and 2), genotoxic
carcinogens are clearly more abundant in the highest potency
range, and nongenotoxic carcinogens are more abundant in the
lowest potency range.
As suggested by Tennant et al. (1), compounds obtained from
the literature can be affected by serious bias. One possibility, for
instance, isthatmainlygenotoxiccompoundswereusedforsubse-
quentcarcinogenicity studies. This, howeverdoesnotseemtobe
thecaseforourdatabase. Inourdatabaseof113chemicals, wehave
67genotoxiccompounds(59%)and46nongenotoxiccompounds
(41%). InthedatabaseofTennantetal. thereare24genotoxiccom-
pounds (67%) and 12 nongenotoxiccompounds (33%).
A second possiblebias is represented by the factthat we could
have started from adatabase much richer in carcinogens than the
database ofTennant etal. (1) forourlong-term studies in rodents.
However, fromthedatabaseofGold etal. (4-6), 492compounds
can be defined as positive carcinogens ( - 50%) and 483 com-
pounds as doubtful or negative carcinogens ( - 50%). From the
global database ofTennant etal., 44chemicals ( - 60%) canbe
defined as positive carcinogens and 29 chemicals ( 40%) as
doubtful or noncarcinogens.
The chemicals in Tennant's database were studied in a blind
fashion; this is not the case for our database. Here we have two
possibilities: a) a given chemical was already known to be a
genotoxic agent. It is difficult in this case to envisage how this
could havecaused abias by increasing thepotency intheoutcome
oflong-term experiments in rodents; b) thechemical wasalready
known to be acarcinogen. Ifthis caused a bias ofheavily favor-
ing thepublication ofpositive data interms ofgenotoxicity, most
ofthecarcinogens ofourdatabase wouldbegenotoxic, but wedo
nothave ahigher proportionofgenotoxic carcinogens than Ten-
nant et al. In conclusion, in our opinion, the fact that the
chemicalsofTennant's database weretested blindcannot explain
the discrepancies with our database.
We have also assessed whether the fact that in Wuirgler's
database amuch larger spectrum ofshort-term tests isconsidered
than in Tennant's database could bepartly responsible forthedif-
ference foundbetween thetwodatabases. Forthispurpose, toim-
prove the correspondence between the short-term tests con-
sidered by us andTennantwehaveusedthepooled results obtain-
ed in Salmonella as a single test; considered the pooled results
for sister chromatid exchanges as a single test; considered mam-
malian cytogenetics in vitro as a single test, and finally, used the
mutagenicity data in mouse lymphoma L5178Y cells. With this
restriction in the spectrum ofshort-term tests, we could define
only 19 chemicals as genotoxic and only 5 chemicals as
nongenotoxic. Genotoxic chemicals appeared, however, 192
times more potent than nongenotoxic ones.
To further explore the reasons for theobserved differences we
examined our intersection database and that ofTennant in terms
ofdifferent chemical classes (Fig. 3). The histogram in Figure
3 clearly shows thatthetwodatabases are ratherdifferentnitroso-
compounds, nitrogen mustards, hydrazine derivatives, and
polycyclic aromatic hydrocarbons are absent in Tennant's
database and nitrocompounds, alcohols, andphenols areheavily
underepresented. Esters and carbamates, aromatic and
heterocyclic amines and amides, and halogenated aromatics are
more abundant (in terms ofpercentage) in Tennant's database.
These differences in terms ofchemical classes are probably suf-
ficient to explain most of the differences in behavior of the
Wurgler-Gold database versus the Tennant database. If
nitrosocompounds, nitrogen mustards, andhydrazine derivatives
areexcluded from the Wurgler-Gold database, thedifference in
potency between genotoxic and nongenotoxic carcinogens is
reduced roughly by half(Table4). Even more important, ifonly
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FiGuRE 3. Subdivision ofchemicals by chemical class in the database of
Wurgler-Gold (7,8) and inthedatabase ofTennant (1). Ifmorethan one
characterizing group was present in a given chemical, thatchemical was
placed in morethan onechemical class.
esters and carbamates, aromatic and heterocyclic amines and
amides, andhalogenatedaromatics (thepredominantclassesin
Tennant's database) are considered in the Wurgler-Gold
databases, thangenotoxiccarcinogens areonlyfivetimes more
potentthannongenotoxic ones (Table4).
Atthis point, our results force thequestionofthe represen-
tativityofdifferentdatabases. Wehave no reasonforconsider-
ingour database moreorlessrepresentative thanTennant's. Our
database (113 chemicals) includes only 4 chemicals in Tennant's
databaseandisthereforeclearly ofadifferentnature. Perhaps
thetruthislocatedsomewhereinbetweenthesituationdepicted
by ourdatabaseandthatdepictedbythe databaseofTennantand
varies fromchemical class tochemical class.
Wealsoinvestigated whether somechemicalclasses show a
definitetrend, inthe sensethatthey wereespecially richin po-
tent or weakcarcinogens. For this purpose we assembled the
databaseofWurgler-GoldandTennant. Weobtainedasetof141
differentchemicals satisfying ourdefinitions forgenotoxic or
nongenotoxiccarcinogens. Wesubdividedthislargersetinthree
parts: 47 mostpotentcarcinogens, 47 averagecarcinogens and
47weakcarcinogens. Thedistribution inthesethreesubsetsfor
each chemical class isgivenin Figure 4.
Looking atFigure4, sometrendsbecome apparent. Aromatic
andetherocyclicaniinesandamides, azocompounds, nitrocom-
pounds, alcohols and phenols, esters and carbamates, show a
clear prevalence in the subclass ofweak carcinogens. On the
H- of cheical.
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FIGURE 4. ThedatabasesofWiirgler-Gold(7,8)andTennant(I) werefused.
A database of 141 chemicals (according to our definition of genotoxic or
nongenotoxiccarcinogens) was obtauied. The47 mostpotentchemicals are
thefarleftcolumnsofeach groupofthreecolumns; the47chemicalsofin-
termediate potency arethecetalcolumns, andthe47 leastpotentchemicals
arethe farrightcolumns.
contrary, nitrosocompounds, hydrazine derivatives, and
nitrogenmustards areclearlypreferentially representedinthe
subclass ofthe most potentcarcinogens.
In addition, we can alsoobserve ageneral trendofenriche-
mentingenotoxiccarcinogens, goingfromthesubsetofweak
carcinogens to the subset ofpotent carcinogens. Halogenated
aliphatics andhalogenated aromaticscouldbe anexception to
thisgeneraltrend. Halogenatedaromatics areall nongenotox-
ic in ourdatabase, and for several halogenated aliphatics pro-
moting activities were found more relevant than initiating ac-
tivities intheratlivermodelofcarcinogenesis (13). Obvious-
ly, the relevance ofthese considerations would be clearly in-
creasedif, inthefuture, wecoulddealwithsignificantly larger
sets ofdata, less subject to statistical fluctuations.
Discussion and Conclusions
Webelievethesedata areimportantbecause webelievethat
theimageofferedbytheworkofTennant(1) (and, as a conse-
quence, therelevance thatshouldimplicitly be given to short-
termtestsforgenotoxicity) shouldbere-equilibratedto asignifi-
cantextent. Ourresults arecomplementary withwhathasbeen
reportedbyBartschandMalaveille(12). Amongtheagentsthat
Ikbe4. Carcinogenic potenc ofgeno c ad nongenoto chem ls fordifferentgroupsofchemical cles.
Numberof Meanvalue,' Ratio Numberof Meanvalue,c Ratio Numberof Meanvalue,' Ratio
chemicals TD,0 (SE) _/+b chemicals TD,0 (SE) -/+ chemicals TD so (SE) -/+
Genotoxic' 67 1.19 (1.44) 40 3.14 (1.65) 23 8.83 (1.73)
44 20 4.6
Nongenotoxice 46 52.5 (1.49) 41 64.1 (1.54) 16 40.4 (2.00)
Genotoxicf 39 0.533 (1.63) 22 1.30 (2.12) 13 3.52 (3.10)
98 47 11
Nongenotoxicf 42 52.2 (1.55) 38 61.5 (1.60) 16 40.4 (2.00)
'AllchemicalsoftheWurgler-Gold intersectiondatabase.
bNongenotoxic/genotoxic.
cNiutocompounds, nitrogenmustards, hydrazinederivatives, andpolycyclic aromatichydrocarbonsexcluded.
dOnlyesters, carbamates, aromatic andheterocyclic aminesandamides, and halogenatedaromaticsincluded.
0Genotoxic ornongenotoxiccarcinogeispositive ornegative inatleastthreetests and atleast75% ofavailable tests.
Genotoxic ornongenotoxic carcinogenspositive ornegative in atleast six tests and at least759% ofavailabletests.
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have been included in the IARCMonographs (agents to which
humansarecurrently exposed) andthathavebeenconsidered to
be carcinogenic, probably carcinogenic, or possibly carcino-
genictohumans, thereisahighprevalence (80-90%)ofgenotox-
ic carcinogens (12). This result, like ours, stresses the impor-
tance of genotoxic carcinogens. After submitting this manu-
script, we were informedby L. S. Gold (personalcommunica-
tion) that our observation holds also when looking only at
mutagenicity in Salmonella: "more toxic carcinogens are
significantly more likely to be mutagenic than less toxic car-
cinogens" (14). Inaddition, going from ahighestdaily doseof
less than 1 mg/kg/day toahighestdailydoseofmorethan 1000
mg/kg/day, thefractionofcarcinogensmutagenicinSalmonella
decreases regularly from 71-76% to 28-13% in mice and rats,
respectively (L. S. Gold, personal communication).
Thecompounds inourpresentanalysis have beenconsidered
(both forcarcinogenicityandgenotoxicity) only astestedathigh
subtoxic dosages. Thequestion iswhatwill theextrapolation of
potenciesatlowerdosesbe? Genotoxiccarcinogens couldhave
a more linear or less sublinear extrapolation at low doses than
nongenotoxic carcinogens. Inthiscase, thedifferenceinpotency
betweengenotoxic andnongenotoxic carcinogens atdoses rele-
vant to human exposure could be even greater than the degree
shown in this report. We do not know ifthe globality ofcar-
cinogenicityexperiments, withgenotoxic ornongenotoxic car-
cinogens, respectively, tends to showasystematicdifference in
the dose-response curve. Perhaps this could be an interesting
field for future investigations.
Promoting and epigenetic effects are probably relevant car-
cinogenicity components both in rodents and inhumans. Little
is known about the extrapolability from rodents to humans of
thesekinds ofeffects. Itisnoteven known ifshort-term in vitro
tests forthesetypes ofeffects will becometechnically possible
in the near future. At present, we can most likely protect
ourselves much better from the genotoxic component of car-
cinogenicity ratherthan fromthepromotion-epigenetic compo-
nent. It is therefore important that studies to better assess the
relevance to humans of nongenotoxic carcinogens be more
thoroughly developed.
Itseems, however, thatforacompletely newchemical, short-
termgenotoxicity testsperform ausefultask; notonlydothey in-
form us about one of the two major components of the car-
cinogenetic process (irreversible alterations inthegenome), they
alsotendtodetectafractionofratherpotentcarcinogens. There
are nongenotoxic carcinogens such as TCDD thatare very po-
tent, butthistypeofepigeneticcarcinogenisapparently rare. For
anoncovalentinteraction toinduceapotenteffect, ahighaffinity
toaspecificcellular receptor isexpected. Fromaprobabilistic
pointofview, foramoleculeunrelatedtotheconformationofthe
receptor itself, having good complementarity with a cellular
receptor should be a rare event (12).
Our results seem to modify the impression offered by the
results ofthe work published by Tennant and co-workers (1).
They seem tosuggestthat, evenifshort-termgenotoxicity tests
are not very good predictors of carcinogenicity in rodents
becausethey candetectonly afractionofthefactorsthatarerele-
vant for the process of carcinogenesis, they are still useful
because they tendtodetect (as anaverage) the mostpotentcar-
cinogens. This is equivalent to saying that even if irreversible
alterations in the genome (genotoxic effects) are not the only
component, they arestillavery important(oftenthemostimpor-
tant) component ofthe process ofchemical carcinogenesis.
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